MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaad.2018.05.1243

Медицинская библиотека · Journal of the American Academy of Dermatology · 2018

Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients.

López-Lerma Ingrid, Peñate Yeray, Gallardo Fernando, Martí Rosa M, Mitxelena Josune, Bielsa Isabel, Velasco-Tamariz Virginia, Yanguas-Bayona Juan I, Sánchez-Sambucety Pedro, García-Patos Vicente, Ortiz-Romero Pablo L, Pujol Ramón M, Estrach Teresa

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma of mature cytotoxic T cells. Initially, patients with SPTCL were treated with doxorubicin-based polychemotherapy.

OBJECTIVE

To analyze clinical, biologic, immunophenotypical, molecular, imaging, treatment, and outcome data reflecting the current state of knowledge.

METHODS

A retrospective multicenter study of 16 patients with SPTCL that was diagnosed between 1996 and 2016.

RESULTS

The female-to-male ratio was 1.7. The median age at diagnosis was 46.5 years. Patients presented with multiple nodular or plaque-like lesions preferentially affecting the legs and/or trunk. Histopathology typically showed a lobular panniculitis with individual adipocytes surrounded by atypical lymphocytes, usually with a CD3+, CD4-, CD8+, CD56-, TIA1 cytotoxic granule associated RNA binding protein 1-positive phenotype and high proliferation rate. SPTCL was associated with autoimmune diseases in 25% of patients, and with the development of hemophagocytic syndrome in 18% of patients. Oral steroids alone or in combination with low-dose methotrexate or cyclosporine A were the most common initial treatment, achieving a complete response in 85% of the treated patients. The median follow-up time was 14 months. The 5-year disease-specific survival rate was 85.7%.

LIMITATIONS: This was a retrospective study.

CONCLUSIONS

SPTCL has an excellent prognosis. Immunosuppressive agents can be considered for first-line treatment.

Для цитирования: López-Lerma Ingrid, Peñate Yeray, Gallardo Fernando, Martí Rosa M, Mitxelena Josune, Bielsa Isabel, Velasco-Tamariz Virginia, Yanguas-Bayona Juan I, Sánchez-Sambucety Pedro, García-Patos Vicente, Ortiz-Romero Pablo L, Pujol Ramón M, Estrach Teresa. Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients.. Journal of the American Academy of Dermatology. 2018. DOI: 10.1016/j.jaad.2018.05.1243.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.